Beyond Bethesda Part 1

Available: August 18, 2020                       REGISTER HERE

 

One (1) Category 1A CME Credit available for this course.

 

Presented by: Alan J. Shienbaum, DO
Disclosures: None

Dr. Alan J. Shienbaum is a board-certified pathologist who is in private practice at Pathology Associates of Northeastern Pennsylvania and Keystone Medical Laboratories.  Pathology Associates was established in 1958 and is Northeastern Pennsylvania’s premier pathology group. Keystone Medical Laboratories was opened in 2008 and is a sister company of Pathology Associates. Additionally, Dr. Shienbaum is on the medical staff at Commonwealth Health Moses Taylor Hospital in Scranton, Pennsylvania.

 

In 1994, Dr. Shienbaum earned his Doctor of Osteopathic Medicine degree from the Philadelphia College of Osteopathic Medicine in Philadelphia, Pennsylvania. He then went on to complete his residency in Anatomic Pathology and Clinical Pathology at Temple University Hospital, followed by a fellowship in Cytopathology at MCP/Hahnemann University Hospital.

 

Dr. Shienbaum holds the position of President of the American Osteopathic College of Pathologists, the premier membership organization for osteopathic physicians specializing in the field of pathology. He also holds board certification in Anatomic Pathology, Clinical Pathology, and Cytopathology by the American Board of Pathology.

 

Dr. Shienbaum’s clinical expertise encompasses oncologic surgical pathology, fine needle aspiration cytopathology, gastrointestinal pathology, breast pathology, gynecologic pathology, head and neck pathology, pulmonary pathology, and medical directorship of clinical laboratories.

 

 

 

The Bethesda Reporting system represents the standard of care.

 

Lecture objectives:

  1. Understand the six diagnostic categories in the Bethesda reporting system for thyroid cytopathology
  2. Be familiar with the clinical implications of each diagnostic category

 

Needs Assessments

  1. New methods of diagnosis or treatment
  2. Advances in medical knowledge

 

Core Competencies: 2,3,6,7

 

Beyond Bethesda Part 2 Incorporating Molecular Studies in the Interpretation of Thyroid FNA

Available: August 25, 2020          REGISTER HERE

 

One (1) Category 1A CME Credit available for this course.

 

Presented by: Alan J. Shienbaum, DO
Disclosures: None

 

The Bethesda Reporting system represents the standard of care.

 

The Bethesda Reporting system represents the standard of care.

Lecture objectives:

  1. Understand the six diagnostic categories in the Bethesda reporting system for thyroid cytopathology
  2. Be familiar with the clinical implications of each diagnostic category
  3. Know and apply the various ancillary molecular tests available which serve as an adjunct the thyroid FNA

 

Needs Assessments

  1. New methods of diagnosis or treatment
  2. Advances in medical knowledge

 

Core Competencies: 2,3,6,7

 

COVID Testing: Promises and Pitfalls

Date Available: September 29, 2020          REGISTER HERE

 

One (1) Category 1A CME Credit available for this course.

 

Presented by: Chaya Prasad, MD, MBA
Disclosures: 

Dr. Prasad is an Associate Professor of Pathology, College of Osteopathic Medicine of the Pacific. She received her Certificate in Clinical and Anatomic Pathology, Am. Board of Pathology in 1992.  In 2013 Dr. Prasad received her MBA from Western Governors University.

1991-1993 Pathology Fellow, Brigham and Women’s Hospital
1990-1991 Surgical Pathology Fellow, Oregon Health Science University
1986-1990 Pathology Residency, Oregon Health Sciences University
1982 M.D. Bangalore Medical College, India

 

 

 

Lecture objectives:

Needs Assessments:

 

Core Competencies:

A Pathologist Review of Selected Bone and Soft Tissue Tumors

Available: January 12, 2021            REGISTER HERE

One (1) Category 1A CME Credit available for this course.

 

Presented by: Steven A. Gustafason, DO, Hannah Borchelt, Student Doctor
Disclosures: None

Dr. Steven A. Gustafson is board certified in Clinical Pathology and Hematopathology.

In 1996, Dr. Gustafson earned his Doctor of Osteopathic Medicine degree from Des Moines University College of Osteopathic Medicine. He then went on to complete his residency in Anatomic Pathology and Clinical Pathology at University of Missouri, Kansas City School of Medicine, followed by a numerous fellowships in Hematopathology, Surgical Pathology, Chemical Pathology, and Pediatric Pathology.  He has lectures and conducted research on national and international levels, as well as authored and co-authored multiple peer-review publications.  He is a reviewer for the Journal of Histotechnology.  He currently serves on the faculty of William Carey University College of Osteopathic Medicine as an Associate Professor of Preclinical Sciences.  In his spare time, he volunteers for USA boxing as a ringside physician.

 

 

Lecture objectives:

  1. Have a better understanding of select non-neoplastic and neoplastic bone and soft tissue tumors.
  2. Better recognize the morphologic spectrum of different bone and soft tissue neoplasms.
  3. Better recognize the radiologic characteristics of bone diseases and how to incorporate them into making a diagnosis.
  4. Understand how to incorporate ancillary diagnostic techniques, molecular and immunohistochemical methods to diagnose these neoplasms and the prognostic implications of them.
  5. Understand how to apply current molecular and immunohistochemical methods and how they are used in the diagnosis of these neoplasms.
  6. Where applicable, understand the World Health Organization’s (Blue book’s) classification system for neoplastic bone and soft tissue diseases.
  7. Utilize the College of American Pathologist check list in reporting bone and soft tissue diseases.

 

Needs Assessments

  1. Review of Updates in Classification
  2. Advances in medical knowledge

 

Core Competencies: 2,3,4,5,6,7

Interesting Topics and Updates Within the Spectrum of Pediatric Pathology

Available: January 26, 2021         REGISTER HERE

 

One (1) Category 1A CME Credit available for this course.

 

Presented by: Steven A. Gustafason, DO, Lindsay G. Bigham, DO, MBS, PGY-1
Disclosures: None

 

Lecture objectives:

  1. Have a better understanding of select non-neoplastic and neoplastic diseases in the pediatric population
  2. Better recognize the morphologic spectrum of different pediatric neoplasms including but not limited to skin, renal, and neurologic disorders.
  3. When applicable, better recognize the radiologic characteristics of these diseases and how to incorporate radiologic imaging into making a diagnosis.
  4. Understand how to incorporate ancillary diagnostic techniques such as molecular and immunohistochemical methods to diagnose these neoplasms and the prognostic implications of them.
  5. Where applicable, understand the World Health Organization’s (Blue book’s) classification system for disease.
  6. Utilize the College of American Pathologist check list in reporting pediatric diseases.

 

Needs Assessments

  1. Review of Updates
  2. Advances in medical knowledge

 

Core Competencies: 2,3,4,5,6,7

Category 1-A CME Webinar Presentations

The American Osteopathic College of Pathologists is pleased to be partnering with the American Osteopathic College of Dermatology for CME programming.

 

The American Osteopathic College of Dermatology is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The American Osteopathic College of Dermatology designates this program for a maximum of one (1) AOA Category 1-A credit per online lecture and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

 

Participants may ask questions of a content expert. A response will be given within 7 business days. Please direct questions to: aocp@aocpath.org

 

 

The lectures made available online by the American Osteopathic College of Pathologists (AOCP) are the intellectual property of the presenter and the AOCP for the purposes of educating the medical community. Any duplication or retransmission of this content without the express written consent of the AOCP is strictly prohibited.